Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 2
Submit an article Journal homepage
338
Views
13
CrossRef citations to date
0
Altmetric
Articles

Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma

Mohamed Mahmoud Gameaa Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
,
Doha Ali Kamala Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta, Egypt
,
Ahmed Atef Doniab Pharmaceutical Technology Department, Faculty of Pharmacy, Menoufia University, Shibin el Kom, Egypt
&
Doaa Salah Hegaba Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta, EgyptCorrespondence[email protected]
Pages 798-804 | Received 17 May 2020, Accepted 07 Jun 2020, Published online: 22 Jun 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Piyush Verma & Khushwant S. Yadav. (2023) Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders. Expert Opinion on Drug Delivery 20:6, pages 773-783.
Read now
Ayda Acar, Ayris Ozturk, Nur Sokmen, Idil Unal & Ilgen Ertam Sagduyu. (2022) Evaluation of platelet-rich plasma efficacy in melasma. Journal of Cosmetic and Laser Therapy 24:1-5, pages 36-39.
Read now

Articles from other publishers (11)

Yu‐Feng Chang, Tai Lin Lee, Oyetewa Oyerinde, Seemal R. Desai, Ali Aljabban, Camden P. Bay, Paul A. Bain & Hye Jin Chung. (2022) Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta‐analysis. Journal of Cosmetic Dermatology 22:4, pages 1168-1176.
Crossref
Israa Gomaa Abd Elraouf, Zakaria Mahran Obaid & Ibrahim Fouda. (2023) Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study. Archives of Dermatological Research 315:6, pages 1763-1770.
Crossref
Alejandro González‐Ojeda, Gabino Cervantes‐Guevara, Jonathan Matías Chejfec‐Ciociano, Guillermo Alonso Cervantes‐Cardona, Daniel Acevedo‐Guzman, Ana Graciela Puebla‐Mora, José Antonio Cortés‐Lares, Mariana Chávez‐Tostado, Andrea Socorro Álvarez‐Villaseñor, Enrique Cervantes‐Pérez, Mónica Patricia Ramos‐Álvarez, Luis Raúl Pacheco‐Vallejo, Francisco José Barbosa‐Camacho & Clotilde Fuentes‐Orozco. (2022) Treatment of melasma with platelet‐rich plasma: A self‐controlled clinical trial. Dermatologic Therapy 35:9.
Crossref
Yağmur Polat & Gülbahar Saraç. (2022) Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment. Dermatologic Therapy 35:7.
Crossref
Tinghan Deng, Fengrui Cheng, Shanshan Guo, Hongbin Cheng & Jingping Wu. (2022) Application of PRP in Chloasma: A Meta-Analysis and Systematic Review. Computational Intelligence and Neuroscience 2022, pages 1-14.
Crossref
Rashmi SarkarMeghna Gupta. (2022) Platelet-Rich Plasma in Melasma—A Systematic Review. Dermatologic Surgery 48:1, pages 131-134.
Crossref
Lingyun Zhao, Meng Hu, Qing Xiao, Runke Zhou, Yu Li, Lidan Xiong & Li Li. (2021) Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis. Dermatology and Therapy 11:5, pages 1587-1597.
Crossref
Ankita Tuknayat, Mala Bhalla & Gurvinder Pal Thami. (2021) Platelet‐rich plasma is a promising therapy for melasma. Journal of Cosmetic Dermatology 20:8, pages 2431-2436.
Crossref
Suruchi GargAnkita Tuknayat. (2021) Tips for managing post-inflammatory hyperpigmentation of acne. Cosmoderma 1, pages 28.
Crossref
Ankita Tuknayat, Gurvinder Pal Thami, Mala Bhalla & Jasleen Kaur Sandhu. (2021) Autologous intralesional platelet rich plasma improves melasma. Dermatologic Therapy 34:2.
Crossref
Xian Ding & Sheng-Xiu Liu. (2021) Progress in the Use of Platelet-Rich Plasma to Treat Vitiligo and Melasma. International Journal of Dermatology and Venereology 4:4, pages 236-241.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.